Search Results 151-160 of 10620 for pv
Learn what may cause vaginal bleeding during pregnancy and when you should see a doctor about it.
All patients must have myelofibrosis (MF) including primary MF, Post-ET, or Post–PV MF. Patients must be planning to undergo allogeneic HSCT (matched or ...
Pathologically confirmed PMF or post ET/PV MF as per the WHO diagnostic criteria with intermediate-1, intermediate -2, or high risk disease according to the IWG ...
Any PV abnormality, stenosis, or stenting (common and middle PVs are admissible) 5. Current left atrial thrombus - 3. Any of the following cardiovascular ...
The objective of this proposal is to assess blood-plasma volume (TBV-PV) status quantitatively in patients with DHF admitted to hospital for volume ...
... PV may enter the trial if they meet the labeled indication for ruxolitinib (e.g., hydroxyurea resistant or refractory):. Escalation Stage 1 patients: who ...
Meet revised 2016 World Health Organization (WHO) criteria for the diagnosis of PV. Hematocrit < 45% before dosing. Phlebotomy requiring defined as ...
Subjects must have a pathologically confirmed diagnosis of PMF as per the WHO diagnostic criteria or post ET/PV MF;; At least Grade 2 marrow fibrosis ...
Diagnosis of Primary Myelofibrosis (PMF) or Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis(post-ET/PV MF) as per revised World Health ...
Also called PA/IVS, this rare congenital heart defect is diagnosed at or shortly after birth. Learn the symptoms and how it's treated.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.